{
    "study_accession": "SDY644",
    "actual_completion_date": null,
    "actual_enrollment": 94,
    "actual_start_date": "2010-10-19",
    "age_unit": "Years",
    "brief_description": "Introduction: Previous priming with avian influenza vaccines results in more rapid and more robust neutralizing antibody responses upon revaccination, but the role CD4+ T cells play in this process is not currently known.",
    "brief_title": "Effect of Influenza A (H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses",
    "clinical_trial": "N",
    "condition_studied": "CD4+ T-cell response to Influenza A (H5N1) vaccine",
    "dcl_id": 2,
    "description": "Previous priming with avian influenza vaccines results in more rapid and more robust neutralizing antibody responses upon revaccination, but the role CD4+ T cells play in this process is not currently known. ",
    "doi": "10.21430/M3T5PSBA22",
    "endpoints": "Pre- and post-vaccination CD4+ T-cell reactivity has been compared using IFN-g cytokine enzyme-linked immunosorbent spot assays with pools of overlapping synthetic peptides as recall antigen.  The neutralizing antibody response to rgA/Indonesia/05/2005 PR8-IBCDC-RG2 virus has been measured by microneutralization assay.",
    "gender_included": "Female, Male",
    "hypothesis": "The specificity of CD4+ T cells influences their ability to help B cells during infection or vaccination.",
    "initial_data_release_date": "2015-09-18",
    "initial_data_release_version": "DR15",
    "intervention_agent": "Inactivated monovalent subvirion influenza A/H5N1/Indonesia/05/05 (clade 2) vaccine",
    "latest_data_release_date": "2015-09-18",
    "latest_data_release_version": "DR15",
    "maximum_age": "  64.00",
    "minimum_age": "  18.00",
    "objectives": "To evaluate how pre- and post-vaccination CD4 T cell responses impact the specificity and magnitude of the antibody response to H5 vaccination.",
    "official_title": "Effect of Influenza A (H5N1) Vaccine Prepandemic Priming on CD4+ T-Cell Responses",
    "sponsoring_organization": "NIAID",
    "target_enrollment": null,
    "workspace_id": 2014,
    "research_focus": [
        "Infection Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM2871",
            "description": "Unprimed healthy adults with no history of H5 vaccination who were not at risk for H5 exposure. Received a prime-boost regimen of influenza A/Indonesia/5/05 vaccine consisting of 2 identical 15ug dose vaccinations separated by 28 days.",
            "name": "Unprimed_15ugdose"
        },
        {
            "arm_accession": "ARM2872",
            "description": "Unprimed healthy adults with no history of H5 vaccination who were not at risk for H5 exposure. Received a prime-boost regimen of influenza A/Indonesia/5/05 vaccine consisting of 2 identical 90ug dose vaccinations separated by 28 days.",
            "name": "Unprimed_90ugdose"
        },
        {
            "arm_accession": "ARM2873",
            "description": "Subjects have previously received either egg-derived inactivated subvirion influenza A/Vietnam/1203/2004 vaccine (clade 1) with HA doses of 3.75-90 ?g in 2005-2006, or 2 doses of baculovirus-expressed recombinant influenza A/HongKong/156/1997 (clade 0) H5 protein in 1997-1998, followed by a single dose of unadjuvanted inactivated subvirion influenza A/Vietnam/1203/04 in 2006. This group received a single 15ug dose of influenza A/Indonesia/5/05 vaccine.",
            "name": "Primed_15ugdose"
        },
        {
            "arm_accession": "ARM2874",
            "description": "Subjects have previously received either egg-derived inactivated subvirion influenza A/Vietnam/1203/2004 vaccine (clade 1) with HA doses of 3.75-90 ?g in 2005-2006, or 2 doses of baculovirus-expressed recombinant influenza A/HongKong/156/1997 (clade 0) H5 protein in 1997-1998, followed by a single dose of unadjuvanted inactivated subvirion influenza A/Vietnam/1203/04 in 2006. This group received a single 90ug dose of influenza A/Indonesia/5/05 vaccine.",
            "name": "Primed_90ugdose"
        }
    ],
    "personnel": [
        {
            "first_name": "Jennifer",
            "last_name": "Nayak",
            "organization": "University of Rochester Medical Center",
            "role_in_study": "Principal Investigator",
            "site_name": "ROC034"
        }
    ],
    "pubmed": [
        {
            "title": "Effect of influenza A(H5N1) vaccine prepandemic priming on CD4+ T-cell responses.",
            "journal": "J Infect Dis.",
            "month": "May",
            "year": "2015",
            "doi": "10.1093/infdis/jiu616. Epub 2014 Nov 6.",
            "pubmed_id": "25378637"
        }
    ],
    "program": [
        {
            "program_name": "NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS)",
            "contract_name": "New York Influenza Center of Excellence"
        }
    ],
    "assay": [
        {
            "measurement_technique": "ELISPOT",
            "number_of_expsamples": 651
        },
        {
            "measurement_technique": "Virus Neutralization",
            "number_of_expsamples": 373
        }
    ],
    "subject": {
        "race": [
            {
                "race": "American Indian or Alaska Native",
                "count": 1
            },
            {
                "race": "Asian",
                "count": 1
            },
            {
                "race": "Black or African American",
                "count": 1
            },
            {
                "race": "White",
                "count": 91
            }
        ],
        "gender": [
            {
                "Female": 59
            },
            {
                "Male": 35
            }
        ]
    }
}
